Login

Dr Chung Kok

Adjunct Senior Research Fellow Centre for Cancer Biology

email Chung.Kok@unisa.edu.au

Research Degree Supervisor

Research

Research focus

Cardiovascular Medicine and Haematology
Oncology and Carcinogenesis
Clinical Sciences
Genetics
Medical Microbiology

Research

Outputs

Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included.

Open access indicates that an output is open access.

Journal Articles

Year	Output
2023	Eşkazan, AE, Kok, CH, Yeung, D, Dalal, J & Tiribelli, M 2023, 'Editorial: advances in the treatment of chronic myeloid leukemia', Frontiers in Oncology, vol. 13, article no. 1166588, pp. 1-3. Open access 3
2023	Hiwase, D, Hahn, C, Tran, ENH, Chhetri, R, Wang, P, Kumar, S, Brown, A, Scott, H, Kok, CH & Shah, MV and 41 other authors 2023, 'TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype', Blood, vol. 141, no. 9, pp. 1087-1091. Open access 6 1 1
2023	Kok, CH, Saunders, VA, Dang, P, Shanmuganathan, N, White, D, Branford, S, Yeung, D & Hughes, TP 2023, 'Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib', Blood Cancer Journal, vol. 13, no. 1, pp. 1-9. Open access
2023	Kutyna, MM, Loone, S, Saunders, VA, White, DL, Kok, CH & Hiwase, DK 2023, 'Solute carrier family 29A1 mediates in vitro resistance to Azacitidine in Acute Myeloid Leukemia cell lines', International Journal of Molecular Sciences, vol. 24, no. 4, article no. 3553, pp. 1-14. Open access
2023	Shah, MV, Tran, ENH, Shah, S, Chhetri, R, Brown, AL, Scott, HS, Kumar, S, Hahn, CN, Kok, CH & Hiwase, DK and 12 other authors 2023, 'TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms', Blood Cancer Journal, vol. 13, no. 1, article no. 51, pp. 1-9. Open access 1
2023	Shanmuganathan, N, Wadham, C, Shahrin, NH, Feng, J, Thomson, D, Wang, P, Kok, CH, King, RM, Kenyon, RR, Lin, M, Ross, DM, Yeung, DT, Scott, HS, Schreiber, AW & Branford, S and 9 other authors 2023, 'Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention', Haematologica: The Hematology Journal, vol. 108, no. 9, pp. 2380-2395. Open access
2023	Sharplin, K, Proudman, W, Chhetri, R, Tran, ENH, Choong, J, Kutyna, M, Selby, P, Sapio, A, Friel, O, Khanna, S, Singhal, D, Damin, M, Ross, D, Yeung, D, Thomas, D, Kok, CH & Hiwase, D 2023, 'A personalized risk model for azacitidine outcome in myelodysplastic syndrome and other myeloid neoplasms identified by machine learning model utilizing real-world data', Cancers, vol. 15, no. 16, article no. 4019, pp. 1-14. Open access
2022	Shanmuganathan, N, Wadham, C, Thomson, D, Shahrin, NH, Vignaud, C, Obourn, V, Chaturvedi, S, Yang, F, Feng, J, Saunders, V, Kok, CH, Yeung, D, King, RM, Kenyon, RR, Lin, M, Wang, P, Scott, H, Hughes, T, Schreiber, AW & Branford, S 2022, 'RNA-based targeted gene sequencing improves the diagnostic yield of mutant detection in chronic myeloid leukemia', Journal of Molecular Diagnostics, vol. 24, no. 7, pp. 803-822. Open access 3

External engagement & recognition

Collaborations

External engagement & recognition

Collaborations

Organisation	Country
Australasian Leukaemia and Lymphoma Group	AUSTRALIA
Istanbul University	TURKEY
Mayo Clinic	UNITED STATES
Novartis Institutes for Biomedical Research	UNITED STATES
Novartis Pharmaceuticals	UNITED STATES
Royal Adelaide Hospital	AUSTRALIA
SA Pathology	AUSTRALIA
South Australian Health and Medical Research Institute (SAHMRI)	AUSTRALIA
University of Adelaide	AUSTRALIA
University of South Australia	AUSTRALIA
University of Udine	ITALY

Teaching & student supervision

Teaching & student supervision

Research degree supervision

Supervisions from 2010 shown

Thesis title	Student status
Enhanced bioinformatics and machine learning for improved risk stratification and outcome prediction in chronic myeloid leukaemia	Current

more less